Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Non-Current Assets: 2014-2025

Historic Non-Current Assets for AC Immune (ACIU) over the last 9 years, with Sep 2025 value amounting to $72.3 million.

  • AC Immune's Non-Current Assets rose 10.61% to $72.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $72.3 million, marking a year-over-year increase of 10.61%. This contributed to the annual value of $72.3 million for FY2025, which is N/A change from last year.
  • Latest data reveals that AC Immune reported Non-Current Assets of $72.3 million as of Q3 2025, which was up 102,409.11% from $70,560 recorded in Q2 2025.
  • In the past 5 years, AC Immune's Non-Current Assets ranged from a high of $9.1 billion in Q2 2021 and a low of $67,257 during Q4 2024.
  • Its 3-year average for Non-Current Assets is $53.4 million, with a median of $64.3 million in 2023.
  • Its Non-Current Assets has fluctuated over the past 5 years, first spiked by 143,142.71% in 2021, then crashed by 99.90% in 2024.
  • AC Immune's Non-Current Assets (Quarterly) stood at $63.8 million in 2021, then decreased by 5.86% to $60.0 million in 2022, then climbed by 8.26% to $65.0 million in 2023, then plummeted by 99.90% to $67,257 in 2024, then grew by 10.61% to $72.3 million in 2025.
  • Its last three reported values are $72.3 million in Q3 2025, $70,560 for Q2 2025, and $65.6 million during Q1 2025.